All In MedTech

Device Trial Radar · NCT05145192

COSMED K5 Validation and Reliability Study

Validity and Reliability of the K5 Wearable Metabolic System During High-Intensity Treadmill Testing in Healthy, Young Adults

Last checked: Nov 19, 2026Latest source record: Jan 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

34

Actual

Start

Nov 29, 2021

Primary completion

Oct 10, 2023

Study completion Oct 10, 2023

Sponsor

Lead sponsor
Baylor Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 6, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 20 years, up to 29 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To determine the validity of the K5 metabolic system breath-by-breath analysis setting during a high intensity treadmill running protocol compared to the criterion ParvoMedics TrueOne® 2400 automated metabolic gas analysis system. To determine the test-retest reliability of the K5 metabolic system breath-by-breath analyzer during a high intensity treadmill protocol (Bruce Protocol).

Conditions

  • Cardiopulmonary
  • Exercise

Interventions

  • COSMED K5 CPET (Cardiopulmonary Exercise Test)Device

    In this randomized crossover trial of eligible adults, we will compare peak measurements of oxygen consumption (VO2) and carbon dioxide production (VCO2) during three maximal cardiopulmonary stress exercise tests (CPET), each seven to ten days apart. Subjects will be randomized into either the K5 or ParvoMedics (PM) group for their first CPET using a 1:1 randomization scheme and will serve as their own control in the subsequent test seven to ten days after the previous one. After both a K5 and a PM CPETs have been completed, the participants will complete an additional K5 CPET for test-retest reliability. A within-subjects analysis will be performed.

  • ParvoMedics CPETDevice

    ParvoMedics CPET

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Oxygen consumption (VO2), mL/minTime frame: At first assessment, during week one.
  2. Oxygen consumption (VO2), mL/minTime frame: At second assessment, during week two.
  3. Oxygen consumption (VO2), mL/minTime frame: At third assessment, during week three.

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Baylor Scott and White Sports Therapy and Research

    Frisco, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.